日本語 
B-MAP Inc. is pleased to announce that it has today signed a memorandum of understanding regarding collaboration with IGNIS LTD., with the aim of enhancing the Company’s corporate value by developing and providing a business management system that utilizes AI that goes beyond the scope of existing medical business support tools.
In addition to the wireless communication technology and highly secure system construction and operation know-how that we have cultivated since our founding, we have a strong pipeline of applications in various industrial fields, including the medical industry.
Meanwhile, IGNIS has a track record of successfully delivering numerous B2C services, and has been involved for approximately 10 years in the development and operation of “Forest,” a SaaS for medical institutions that has been used by hundreds of thousands of people to date. The IGNIS Group is deeply committed to the medical field and has “down-to-earth” domain knowledge, as well as advanced AI implementation technology to systematize “winning principles for the medical field.”
Also Read: Eisai and Henlius Sign Japan Rights Deal for Serplulimab
Although the private medical treatment market continues to expand, the field remains labor-intensive, and inefficient operations are hindering profitability.
The two companies concluded this agreement based on the belief that combining IGNIS‘s “clinical knowledge” and “AI technological capabilities” with our “network and sales capabilities in the medical industry” and “high-security system construction and operation know-how” will create powerful synergies that will revolutionize the market structure.
Our goal is to go beyond the framework of existing business support tools and build a next-generation clinic management system in which AI plays a central role in clinic management. This will enable us to create clinics that are structurally highly profitable while improving medical quality, even in an era of a declining working population.
The collaboration based on this agreement will lead to further enhancement of our corporate value.
SOURCE: PRTimes
English